Novanta Inc Stock Price, News & Analysis

Novanta Inc. (NASDAQ: NOVT) announced that its Chair & CEO, Matthijs Glastra, along with CFO Robert Buckley, will present at the J.P. Morgan Healthcare Conference in San Francisco, California, on January 10, 2023. As a global supplier of technology solutions for medical and advanced industrial OEMs, Novanta specializes in photonics, vision, and precision motion technologies. The company's expertise enables it to deliver high-performance components tailored to customer needs, driving growth through innovation and commitment to success.

Novanta reported a 26% increase in GAAP revenue to $223 million for Q3 2022, alongside a 66% rise in diluted EPS to $0.63. The company posted a net income of $22 million, up from $13.6 million year-over-year. Adjusted EBITDA was $49 million, reflecting robust performance despite inflationary pressures. Novanta raised its 2022 guidance, expecting GAAP revenue of $857-$859 million for the year, indicating 21-22% growth. Customer demand remains strong, with backlog levels near record highs.

Novanta Inc. (NASDAQ: NOVT), a technology partner for medical and advanced tech equipment manufacturers, announced that CEO Matthijs Glastra and CFO Robert Buckley will present at the Baird 2022 Global Industrial Conference in Chicago on November 9, 2022. The company specializes in providing core technology solutions that enhance OEMs' competitive advantage, focusing on photonics, vision, and precision motion technologies. Novanta’s commitment to innovation and customer success drives its growth in delivering precision-engineered components.

Novanta Inc. (NASDAQ: NOVT) will release its third quarter 2022 results on November 8, 2022. A conference call is scheduled for 10:00 a.m. ET on the same day, which can be accessed by dialing (888) 346-3959 or through a live webcast on the company's website. The audio replay of the call will be available for listening approximately three hours post-event until January 2, 2023. Novanta specializes in advanced technology solutions for medical and industrial OEMs, focusing on precision and performance.

Novanta reported a strong second quarter in 2022 with GAAP revenue of $215.4 million, a 29% increase year-over-year. Consolidated net income reached $17.5 million, reflecting a 49% rise in diluted EPS to $0.49. Adjusted EPS improved by 26% to $0.78, while adjusted EBITDA was $45.0 million. With bookings up 25% year-over-year, the company raised its full-year guidance, forecasting revenue between $848 million and $852 million.

Novanta Inc. (NASDAQ: NOVT) will release its second quarter 2022 results on August 9, 2022, followed by a conference call at 10:00 a.m. ET. Interested parties can access the call by dialing (888) 346-3959 or through a live webcast on the company’s website. A replay will be available approximately three hours post-call and will remain accessible until October 3, 2022. As a leader in technology solutions for healthcare and advanced industries, Novanta enables OEMs with precision and performance in their applications.

Novanta Inc. (NASDAQ: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at the CJS Securities 22nd Annual “New Ideas” Summer Conference on July 12, 2022, in Greenwich, CT. As a leading supplier of technology solutions for medical and advanced industrial OEMs, Novanta focuses on precision technology, including photonics and motion control. The company emphasizes innovation and customer success, aiming to provide a competitive edge to its partners. For more details, visit www.novanta.com.

Novanta Inc. (Nasdaq: NOVT) announced that CFO Robert Buckley will present at Baird's 2022 Global Consumer, Technology & Services Conference on June 7, 2022, in New York, NY. Novanta is a leader in providing technology solutions for medical and advanced industrial OEMs, focusing on photonics, vision, and precision motion. Their expertise enables them to deliver high-performance core components tailored to demanding applications. For more information, visit www.novanta.com.

Novanta Inc. (NASDAQ: NOVT) announces that CFO Robert Buckley and EVP Charlie Webster will present at the William Blair 42nd Annual Growth Stock Conference on June 6, 2022, in Chicago, IL. The company is a leading global supplier of technology solutions for medical and advanced industrial OEMs, focusing on photonics, vision, and precision motion. With a commitment to innovation and customer success, Novanta engineers components that deliver precision performance tailored to demanding applications.